Drug Database
Back to search

Japan· JP-7290419G3021

ガドクアトラン水和物

A gadoquatrane product containing ガドクアトラン水和物, registered in Japan by バイエル薬品, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

On Japan’s NHI price listATC V08CA13

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedガドクアトラン水和物ATCV08CA13REGISTER NO.JP-7290419G3021PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ガドクアトラン水和物Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gadoquatrane is registered in 3 of 19 countries.

Countries holding a registration under ATC V08CA13 (gadoquatrane), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose
Search gadoquatrane products by name

Gadoquatrane · ATC V08CA13

3 / 19 countries

  • Japan
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ガドクアトラン水和物
Manufacturer
バイエル薬品
Country
Japan (JP)
ATC code
V08CA13
ATC class
Gadoquatrane
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V08CA13

Gadoquatrane, as other registers publish it.

All gadoquatrane products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cc9a0756-ae73-4323-abd1-f1f6710b8b2f
GET /v1/drugs/cc9a0756-ae73-4323-abd1-f1f6710b8b2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "２５．７９％１０ｍＬ１筒",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "7290419G3021",
  "category": "注射薬",
  "price_yen": 8510,
  "generic_name": "ガドクアトラン水和物",
  "product_name_jp": null,
  "therapeutic_class": "7290",
  "transitional_expiry": "8510"
}
API referenceMCP serverPlans

See everything about gadoquatrane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console